Public Calendar: April 16 - 22, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Stephen M. Ostroff, M.D., Acting Commissioner of Food and Drugs
Event Date : 04/19/2017 - 04/19/2017
Location : Atlanta, GA
Subject : Panel Discussion on Administration Efforts to Address the Prescription Drug Abuse and Heroin Epidemics
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Acting Deputy Commissioner for Operations
No Significant Event
Official Name : Erik Mettler, Acting Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs
No Significant Event
Official Name : Luciana Borio, M.D., Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date : 04/18/2017 - 04/18/2017
Location : College Park, MD
Subject : Patient-Focused Drug Development(PFDD)
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
Event Date : 04/19/2017
Location : Ottawa, Canada
Subject : Global Tobacco Regulators Forum
FDA Participant/Group : DAVID ASHLEY; MITCHELL ZELLER; CAITLIN ADDORISIO;
Non FDA Participant/Group : Several Represenatives from World Health Organization/Health Canada
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel
Event Date : 04/18/2017 - 04/18/2017
Location : Silver Spring, MD
Subject : Natco Pharma Limited, Abbreviated New Drug Application(ANDA)
FDA Participant/Group : MARY HIATT; MAARIKA KIMBRELL; KIM DETTELBACH; MARTIN SHIMER; CHRISTOPHER PRUITT; ERIN KEPPLINGER; MARYLL TOUFANIAN;
Non FDA Participant/Group : Lara FitzSimmons, Trang Hoang, William Rakoczy (Rakoczy Molino Mazzochi Siwik LLP); Pramod Dahibhate, Sofia Mumtaz (Lupin Pharmaceuticals);